Clinical trial design for stem cell therapies in stroke: What have we learned?
Author:
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Neurochemistry International
- Vol. 106, 108-113
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- A Double-Blind Placebo-Controlled Clinical Evaluation of Multistem for the Treatment of Ischemic StrokeInternational Journal of Stroke, 2013
- Intra-Arterial Bone Marrow Mononuclear Cells in Ischemic StrokeStroke, 2012
- Autologous Mesenchymal Stem Cells in Chronic StrokeCerebrovascular Diseases Extra, 2011
- Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitisExperimental Neurology, 2011
- The risk of putting something where it does not belong: Mesenchymal stem cells produce masses in the brainExperimental Neurology, 2011
- Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in strokeBrain, 2011
- Effects of Administration Route on Migration and Distribution of Neural Progenitor Cells Transplanted into Rats with Focal Cerebral Ischemia, an MRI StudyJournal of Cerebral Blood Flow & Metabolism, 2009
- Effect of Constraint-Induced Movement Therapy on Upper Extremity Function 3 to 9 Months After StrokeJAMA, 2006
- Stem cells for the treatment of neurological disordersNature, 2006
- Neocortical Neural Sprouting, Synaptogenesis, and Behavioral Recovery After Neocortical Infarction in RatsStroke, 1995